Loading…
Wearable gait device for stroke gait rehabilitation at home
Hemiparesis is a common disabling consequence of stroke that leads to abnormal gait patterns marked by asymmetries in step length, stance, and swing phases. Asymmetric gait patterns are correlated with decreased gait velocity and increased susceptibility to falls that can lead to serious injuries an...
Saved in:
Published in: | Topics in stroke rehabilitation 2021-08, Vol.28 (6), p.443-455 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Hemiparesis is a common disabling consequence of stroke that leads to abnormal gait patterns marked by asymmetries in step length, stance, and swing phases. Asymmetric gait patterns are correlated with decreased gait velocity and increased susceptibility to falls that can lead to serious injuries and hospitalizations.
In this single group, before and after study, treatment with the iStride
TM
gait device, designed to improve the gait patterns of individuals with hemiparesis, is adapted to the home environment. Previously tested in clinical settings, this study investigates if using the iStride
TM
gait device within the home environment can provide safe and effective gait treatment for individuals with hemiparetic gait impairments caused by stroke.
Twelve 30-minute sessions of walking on the device were administered in each participant's home environment. Twenty-one participants who were more than one-year post-stroke received the treatment. The Ten-Meter Walk Test, Timed Up and Go Test, Berg Balance Scale, Functional Gait Assessment, and Stroke Specific Quality of Life Scale were performed before and one week after treatment. Safety, treatment plan compliance, and subjective responses were also recorded during the study period.
Results demonstrate statistically significant improvement on all five outcome measures from before treatment to one week after the last treatment session (p |
---|---|
ISSN: | 1074-9357 1945-5119 |
DOI: | 10.1080/10749357.2020.1834272 |